PD Dr. Susan Jung



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Membranous septum length as predictor for permanent pacemaker implantation after TAVI (2022) Jung S, Ammon F, Smolka S, Moshage M, Marwan M, Achenbach S Conference contribution Further Evidence of Neuroprotective Effects of Recombinant Human Erythropoietin and Growth Hormone in Hypoxic Brain Injury in Neonatal Mice (2022) Klepper S, Jung S, Dittmann L, Geppert CI, Hartmann A, Beier N, Trollmann R Journal article Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure (2021) Pietschner R, Kolwelter J, Bosch A, Striepe K, Jung S, Kannenkeril D, Ott C, et al. Journal article Recombinant Human Growth Hormone Activates Neuroprotective Growth Factors in Hypoxic Brain Injury in Neonatal Mice (2021) Jung S, Terörde K, Dörr HG, Trollmann R Journal article Seizure-induced neuronal apoptosis is related to dysregulation of the RNA-edited GluR2 subunit in the developing mouse brain (2020) Jung S, Ballheimer YE, Brackmann F, Zoglauer D, Geppert CI, Hartmann A, Trollmann R Journal article DMBT1 is upregulated in lung epithelial cells after hypoxia and changes surfactant ultrastructure (2020) Müller H, Schmiedl A, Weiss C, Ai M, Jung S, Renner M Journal article Comeback of Renal Denervation As Treatment Option in Patients with Hypertension (2019) Jung S, Schmieder R Journal article Tissue sodium concentration correlates with hypertrophic vascular remodelling in type 2 diabetes (2019) Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Linz P, Nagel AM, et al. Conference contribution Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes (2019) Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R Conference contribution Disparate effects of the combined therapy of empagliflozin and linagliptin versus metformin and insulin glargine on renal haemodynamics in type 2 diabetes (2019) Ott C, Jung S, Kannenkeril D, Striepe K, Bosch A, Korn M, Bramlage P, Schmieder R Conference contribution
1 2 3 4